Vijayalakshmi Nandakumar-Decision-making and Problem-solving-Best Researcher Award
ARUP/University of Utah-United States
Author Profile
Early Academic Pursuits
Dr. Vijayalakshmi Nandakumar embarked on her academic journey with a Bachelor's degree in Industrial Biotechnology from Anna University, Chennai, India (2002-2006). She pursued further studies, earning a Master's degree in Biology from the University of Alabama at Birmingham (2006-2008) before obtaining a Ph.D. in Genetic Molecular and Cellular Biology from the Keck School of Medicine, University of Southern California (2008-2013).
Professional Endeavors
Her commitment to advancing medical knowledge led her to various postdoctoral fellowships, including roles at the Keck School of Medicine (2013-2014), Mayo Clinic in Clinical Chemistry (2018-2020), and Infection and Immunology (2014-2017). Dr. Nandakumar's research focus extended to molecular immunology during her tenure at the Keck School of Medicine.
Contributions and Research Focus
Dr. Nandakumar's extensive contributions to research are evident through her work at institutions like the Mayo Clinic and the Keck School of Medicine. Her research spans diverse areas, from clinical chemistry to infection and immunology, showcasing a broad spectrum of expertise. Noteworthy projects include investigations into the role of CARD9 in Pneumocystis host defense and the comprehensive study of histone deubiquitinase, MYSM1, in hematopoietic system development.
Accolades and Recognition
Dr. Nandakumar's outstanding contributions to the field have earned her numerous accolades. She received the Young Investigator Award from the Academy of Clinical Laboratory Physicians and Scientists in 2022 and secured the First Place in the Oral Contest at the American Association for Clinical Chemistry Annual Scientific Meeting in 2021. Her excellence was further highlighted by the 2019 Student Abstract Recognition Award and a 2018 U.S Trainee Educational Grant Award.
Impact and Influence
As an Assistant Professor (Clinical) and Medical Director at the University of Utah Department of Pathology, Dr. Nandakumar's influence extends to education, research, and clinical practice. She has left an indelible mark on the field of Clinical Laboratory Sciences, actively engaging in teaching, mentoring, and administrative duties.
Legacy and Future Contributions
Dr. Vijayalakshmi Nandakumar's legacy is marked by her commitment to advancing knowledge and fostering the growth of upcoming professionals. Her ongoing involvement in various professional societies and committees demonstrates her dedication to shaping the future of clinical laboratory medicine. With a rich background in research, teaching, and leadership, Dr. Nandakumar continues to make lasting contributions to the field, leaving an enduring impact on the realms of immunology, clinical chemistry, and laboratory medicine.
Notable Publications
- Multi-targeted prevention and therapy of cancer by proanthocyanidins
- (−)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p 16 INK4a , by reducing …
- The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation
- Control of B cell development by the histone H2A deubiquitinase MYSM1
- Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1